Back to Search
LASZLO BOROS, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1720057441Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
132570-1(NY)
Research & Publications (20)
Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL-positive cells.
PMID 19401345·Clin Cancer Res·2009
8-other
Ethanol diversely alters palmitate, stearate, and oleate metabolism in the liver and pancreas of rats using the deuterium oxide single tracer.
PMID 19248221·Pancreas·2009
7-preclinical
Direct spectrophotometric determination of serum fructose in pancreatic cancer patients.
PMID 19506535·Pancreas·2009
4-observational
Impact of the solvent capacity constraint on E. coli metabolism.
PMID 18215292·BMC Syst Biol·2008
8-other
Use of metabolic pathway flux information in anticancer drug design.
PMID 18811058·Ernst Schering Found Symp Proc·2007
6-review
A randomized phase II trial of two schedules of docetaxel in elderly or poor performance status patients with advanced non-small cell lung cancer.
PMID 17409802·J Thorac Oncol·2007
3-trial
Increased glucose disposal and AMP-dependent kinase signaling in a mouse model of hemochromatosis.
PMID 17971451·J Biol Chem·2007
7-preclinical
In utero nicotine exposure alters fetal rat lung alveolar type II cell proliferation, differentiation, and metabolism.
PMID 17215434·Am J Physiol Lung Cell Mol Physiol·2007
7-preclinical
K-ras codon-specific mutations produce distinctive metabolic phenotypes in NIH3T3 mice [corrected] fibroblasts.
PMID 15994921·Cancer Res·2005
7-preclinical
Fermented wheat germ extract (Avemar) in the treatment of cancer and autoimmune diseases.
PMID 16126993·Ann N Y Acad Sci·2005
6-review
Detection of resistance to imatinib by metabolic profiling: clinical and drug development implications.
PMID 16196499·Am J Pharmacogenomics·2005
6-review
Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor.
PMID 15705899·Cancer Res·2005
7-preclinical
Polymorphism of the TNF-alpha, HSP70-2, and CD14 genes increases susceptibility to severe acute pancreatitis.
PMID 15714129·Pancreas·2005
8-other
[1,2-13C2]-D-glucose profiles of the serum, liver, pancreas, and DMBA-induced pancreatic tumors of rats.
PMID 16258367·Pancreas·2005
7-preclinical
Medicinal chemistry, metabolic profiling and drug target discovery: a role for metabolic profiling in reverse pharmacology and chemical genetics.
PMID 15638788·Mini Rev Med Chem·2005
6-review
Dynamic profiling of the glucose metabolic network in fasted rat hepatocytes using [1,2-13C2]glucose.
PMID 15032751·Biochem J·2004
7-preclinical
Chromosomal aberrations in human lymphocytes exposed to the anticholinesterase pesticide isofenphos with mechanisms of leukemogenesis.
PMID 15234572·Leuk Res·2004
8-other
Metabolic sensitivity of pancreatic tumour cell apoptosis to glycogen phosphorylase inhibitor treatment.
PMID 15599384·Br J Cancer·2004
8-other
Preparation of new 2,3-diphenylpropenoic acid esters - good yields even for the more hindered Z isomers.
PMID 18007429·Molecules·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- INTERLAKES ONCOLOGY & HEMATOLOGY PC, 211 WHITE SPRUCE BLVD.
ROCHESTER, NY 14623 - Phone
- (585) 475-8728
Quick Facts
- NPI
- 1720057441
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile